Author:
Ji Ying,Zhuo Yaoyao,Li Ting,Lian Jingge,Wang Zilin,Guo Xinyu,Kong Dexing,Li Kangan
Abstract
Abstract
Background
To evaluate the technical success and patient safety of magnetic resonance-guided percutaneous microwave coagulation (MR-guided PMC) for breast malignancies.
Methods
From May 2018 to December 2019, 26 patients with breast tumors measuring 2 cm or less were recruited to participate in a prospective, single-institution clinical study. The primary endpoint of this study was the evaluation of treatment efficacy for each patient. Histochemical staining with α-nicotinamide adenine dinucleotide and reduced (NADH)-diaphorase was used to determine cell viability following and efficacy of PMC. The complications and self-reported sensations from all patients during and after ablation were also assessed. The technical success of the PMC procedure was defined when the area of the NADH-diaphorase negative region fully covered the hematoxylin–eosin (H&E) staining region in the tumor.
Results
All patients had a complete response to ablation with no residual carcinoma on histopathological specimen. The mean energy, ablation duration, and procedure duration per tumor were 36.0 ± 4.2 kJ, 252.9 ± 30.9 S, and 104.2 ± 13.5 min, respectively. During the ablation, 14 patients underwent prolonged ablation time, and 1 patient required adjusting of the antenna position. Eleven patients had feelings of subtle heat or swelling, and 3 patients experienced slight pain. After ablation, one patient took two painkillers because of moderate pain, and no patients had postoperative oozing or other complications after PMC. Induration around the ablation area appeared in 16 patients.
Conclusion
MR-guided PMC of small breast tumors is feasible and could be applied in clinical practice in the future.
Critical relevance statement
MR-guided PMC of small breast tumors is feasible and could be applied in clinical practice in the future.
Key points
• MR-guided PMC of small breast tumors is feasible.
• PMC was successfully performed for all patients.
• All patients were satisfied with the final cosmetic result.
Graphical Abstract
Funder
National Natural Science Foundation of China
Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
Publisher
Springer Science and Business Media LLC